Anne Samuel

Stock Analyst at JP Morgan

(1.36)
# 1436
Out of 5,287 analysts
79
Total ratings
46.15%
Success rate
12.07%
Average return
20 Stocks
Name Action Price Target Current % Upside Ratings Updated
Omnicell
Maintains: Neutral
44 36
35.16 2.39% 5 Mar 20, 2025
Veeva Systems
Maintains: Neutral
218 249
239.06 4.16% 6 Mar 20, 2025
Evolent Health
Maintains: Overweight
13 12
9.7 23.71% 12 Mar 10, 2025
IQVIA Hldgs
Maintains: Overweight
240 232
186.39 24.47% 6 Feb 18, 2025
Progyny
Maintains: Neutral
17 23
22.09 4.12% 7 Jan 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
30 48
66.38 -27.69% 5 Nov 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
27 28
28.1 -0.36% 2 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
21 19
19.09 -0.47% 4 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
19 21
24.77 -15.22% 3 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
10 13
4.5 188.89% 3 Sep 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
24 27
39.04 -30.84% 2 Aug 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
7 5
2.98 67.79% 1 Jul 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
86 108
90.41 19.46% 7 Apr 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20 11
n/a n/a 3 Dec 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
30 25
n/a n/a 1 Dec 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
19 20
n/a n/a 1 Nov 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
32 31
n/a n/a 2 Sep 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
12
n/a n/a 1 Jul 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
14 15
n/a n/a 4 Apr 24, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
148 159
n/a n/a 4 Apr 24, 2018